Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 8 de 8
Filtrar
1.
J Investig Allergol Clin Immunol ; 26(6): 366-373, 2016.
Artigo em Inglês | MEDLINE | ID: mdl-27996943

RESUMO

INTRODUCTION: Hymenoptera venom immunotherapy (VIT) is an effective treatment but not one devoid of risk, as both local and systemic adverse reactions may occur, especially in the initial phases. We compared the tolerance to 3 VIT buildup protocols and analyzed risk factors associated with adverse reactions during this phase. MATERIALS AND METHODS: We enrolled 165 patients divided into 3 groups based on the buildup protocol used (3, 4, and 9 weeks). The severity of systemic reactions was evaluated according to the World Allergy Organization model. Results were analyzed using exploratory descriptive statistics, and variables were compared using analysis of variance. RESULTS: Adverse reactions were recorded in 53 patients (32%) (43 local and 10 systemic). Local reactions were immediate in 27 patients (63%) and delayed in 16 (37%). The severity of the local reaction was slight/moderate in 15 patients and severe in 13. Systemic reactions were grade 1-2. No significant association was found between the treatment modality and the onset of local or systemic adverse reactions or the type of local reaction. We only found a statistically significant association between severity of the local reaction and female gender. As for the risk factors associated with systemic reactions during the buildup phase, we found no significant differences in values depending on the protocol used or the insect responsible. CONCLUSIONS: The buildup protocols compared proved to be safe and did not differ significantly from one another. In the population studied, patients undergoing the 9-week schedule presented no systemic reactions. Therefore, this protocol can be considered the safest approach.


Assuntos
Venenos de Artrópodes/administração & dosagem , Dessensibilização Imunológica/métodos , Himenópteros/imunologia , Hipersensibilidade/terapia , Mordeduras e Picadas de Insetos/terapia , Adolescente , Adulto , Idoso , Animais , Venenos de Artrópodes/efeitos adversos , Venenos de Artrópodes/imunologia , Criança , Dessensibilização Imunológica/efeitos adversos , Esquema de Medicação , Feminino , Humanos , Hipersensibilidade/diagnóstico , Hipersensibilidade/imunologia , Tolerância Imunológica , Mordeduras e Picadas de Insetos/diagnóstico , Mordeduras e Picadas de Insetos/imunologia , Masculino , Pessoa de Meia-Idade , Estudos Prospectivos , Índice de Gravidade de Doença , Espanha , Fatores de Tempo , Resultado do Tratamento , Adulto Jovem
8.
Allergol Immunopathol (Madr) ; 33(3): 175-7, 2005.
Artigo em Inglês | MEDLINE | ID: mdl-15946633

RESUMO

Pancreatitis is a rare adverse effect of codeine. We report the case of a 42-year-old man who suffered from epigastric pain 1 hour after taking a tablet containing amoxicillin plus clavulanic acid (500/125 mg) and another tablet containing acetaminophen plus codeine (500/30 mg) for a respiratory infection. He was admitted to the emergency room and was treated with metamizol and pantoprazole. A few minutes after receiving intravenous doses of both drugs he developed a maculopapular and itching eruption with facial angioedema. Laboratory tests showed high levels of serum amylase, GOT, GPT and total bilirubin. Serological tests for several viruses showed no evidence of recent infection. Ultrasonography was negative for biliary lithiasis and showed only cholecystectomy performed in 2000. The patient was sent to our department where skin prick and oral challenge tests were performed with negative results. For ethical reasons, oral challenge with codeine was not carried out. We believe that our patient had codeine-induced pancreatitis. The most likely underlying pathophysiological mechanism was probably codeine-induced spasm of the sphincter of Oddi combined with sphincter of Oddi dysfunction related to a previous cholecystectomy. Allergy departments should be aware of possible non-immunological adverse.


Assuntos
Codeína/efeitos adversos , Pancreatite/induzido quimicamente , 2-Piridinilmetilsulfinilbenzimidazóis , Acetaminofen/administração & dosagem , Acetaminofen/uso terapêutico , Adulto , Combinação Amoxicilina e Clavulanato de Potássio/administração & dosagem , Combinação Amoxicilina e Clavulanato de Potássio/uso terapêutico , Analgésicos/administração & dosagem , Analgésicos/uso terapêutico , Anti-Inflamatórios não Esteroides/uso terapêutico , Antiulcerosos/uso terapêutico , Benzimidazóis/uso terapêutico , Codeína/administração & dosagem , Dipirona/uso terapêutico , Quimioterapia Combinada/administração & dosagem , Quimioterapia Combinada/uso terapêutico , Humanos , Masculino , Omeprazol/análogos & derivados , Omeprazol/uso terapêutico , Pantoprazol , Infecções Respiratórias/tratamento farmacológico , Espasmo/induzido quimicamente , Esfíncter da Ampola Hepatopancreática/efeitos dos fármacos , Sulfóxidos/uso terapêutico , Vômito/etiologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA